Boston Partners boosted its stake in shares of MetLife, Inc. (NYSE:MET) by 0.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,010,623 shares of the financial services provider’s stock after buying an additional 9,845 shares during the period. Boston Partners owned about 0.19% of MetLife worth $110,464,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Signature Estate & Investment Advisors LLC purchased a new position in shares of MetLife during the first quarter valued at approximately $107,000. First Personal Financial Services boosted its position in shares of MetLife by 11.5% in the first quarter. First Personal Financial Services now owns 2,588 shares of the financial services provider’s stock valued at $137,000 after buying an additional 266 shares in the last quarter. Westside Investment Management Inc. boosted its position in shares of MetLife by 583.8% in the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock valued at $140,000 after buying an additional 2,300 shares in the last quarter. Parallel Advisors LLC boosted its position in shares of MetLife by 50.7% in the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock valued at $143,000 after buying an additional 924 shares in the last quarter. Finally, First Mercantile Trust Co. purchased a new position in shares of MetLife during the first quarter valued at approximately $149,000. 74.23% of the stock is owned by institutional investors.

Shares of MetLife, Inc. (NYSE MET) opened at 46.73 on Wednesday. The company has a market capitalization of $49.67 billion, a price-to-earnings ratio of 549.76 and a beta of 1.46. The stock has a 50 day moving average of $48.46 and a 200-day moving average of $47.25. MetLife, Inc. has a one year low of $37.17 and a one year high of $52.07.

MetLife (NYSE:MET) last posted its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The firm had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s revenue was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.83 EPS. On average, equities analysts expect that MetLife, Inc. will post $4.83 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.42%. The ex-dividend date is Thursday, August 3rd. MetLife’s dividend payout ratio is currently 1,777.98%.

TRADEMARK VIOLATION NOTICE: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/08/30/metlife-inc-met-position-raised-by-boston-partners.html.

Several equities analysts recently commented on the stock. BidaskClub raised shares of MetLife from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. TheStreet cut shares of MetLife from a “b-” rating to a “c+” rating in a research note on Monday, August 21st. Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Finally, Langen Mcalenn reissued a “buy” rating on shares of MetLife in a research note on Wednesday, August 16th. Two research analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $58.95.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.